Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Survival of rhNRG-1 in Chronic Systolic Heart Failure
NCT01131637Phase 3Terminated
- Sponsor
- Zensun
- Start
- Apr 2010
- Primary completion
- Jun 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of neucardin in chronic systolic heart failure (HFrEF), sponsored by Zensun. Started Apr 2010; status: terminated.
02
Drugs
neucardin
03
Conditions
chronic systolic heart failure (HFrEF)
Beyond the preview
Go deeper on NCT01131637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01131637.